Stem Cell Research
Published by Elsevier
ISSN : 1873-5061 eISSN : 1876-7753
Abbreviation : Stem Cell Res.
Aims & Scope
Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research.
Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, genomics and translational research.
Special focus of SCR is on mechanisms of pluripotency and description of newly generated pluripotent stem cell lines.
The journal publishes • Original articles • Short reports • Review articles • Communications • Methods and reagents articles • Lab Resource: Stem Cell Line
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.495 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 82 |
Impact Factor
| Year | Value |
|---|---|
| 2024 | 0.80 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 11706 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 924 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,320.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Citation: 1833
Authors: Ruenn Chai, Fatih, May May, Newman Siu Kwan, Andre, Tian Sheng, Manuel, Leo, Chuen Neng, Reida Menshawe, Gerard, Dominique P.V., Sai Kiang
-
Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Citation: 949
Authors: Fatih, Ruenn Chai, Mirjam B., Lars, Andre, Eissa N.E., Leo, Harold V., Pieter A., Gerard, Sai Kiang, Dominique P.
-
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
Citation: 512
Authors: Leo, Sai Kiang, Fatih, Jeffrey S., Imo E., Pieter A., Jan J., Reida Menshawe, Andre, Chuen Neng, Gerard, Dominique P.V.
-
Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies
Citation: 418
Authors: Hannes, Poh Loong, Siew Tein, Blaine W., Thomas C., N. Ray
-
Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction
Citation: 343
Authors: Leo, Sai Kiang, Imo E., Fatih, Ruenn Chai, Angelique A.M., Marie Jose, Chaylendra, Sui Kwan, Andree, Jan J., Pieter A., Gerard, Dominique P.V.
-
Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction
Citation: 334
Authors: Linda W., Robert, Jantine, Arie J., Daniel J., Christian, Krista, Dorien, Jeroen, Leon G., Cees J., Pieter A., Christine L.
-
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Citation: 315
Authors: Stefan R., Leon, Anja, Thomas, Robert, Christine L.
-
Spermatogonial stem cells and spermatogenesis in mice, monkeys and men
Citation: 292
Authors: Adetunji P., Kyle E.
-
Aging alters tissue resident mesenchymal stem cell properties
Citation: 261
Authors: Eckhard U., Christiane, Subramanyam N., Douglas P., Charles L., Abigail E., Philip J., Reza
-
A short G1 phase is an intrinsic determinant of naïve embryonic stem cell pluripotency
Citation: 248
Authors: Diana, Murielle, Pierre-Yves, Yann, Agnieszka, Maxime, Marielle, Suzy, Anna, Roberto, Konstantinos, Pierre